strains were isolated from pediatric patients infected with Haemophilus influenzae. Forty-one strains were found to be resistant to ampicillin, chloramphenicol, and other antibiotics. They were isolated from 20 patients with invasive diseases (meningitis, 16; bacteremia, 4) and 21 with noninvasive diseases (otitis media, 19; conjunctivitis, 2). During this period, 44 patients with invasive diseases were seen (meningitis, 28; bacteremia, 16 both ampicillin and chloramphenicol. Nasopharyngeal samples from 103 children were taken. Furthermore, we studied eight family groups of patients with resistant-H. influenzae meningitis (16 adults and 6 children). The organisms were identified as H. influenzae by Gram stain and growth requirements of factors V and X on Mueller-Hinton agar. Isolates were typed by agglutination with specific antisera (Difco Laboratories) and biotyped by the Kilian method (10). Beta-lactamase production was detected by the rapid acidometric method (18).
tetracycline, 54.5%; and sulfamethoxazole-trimethoprim, 63.6%. No epidemiological relationship could be found among the patients. The presence of asymptomatic carriers was investigated in two nurseries and in eight family groups. From a total of 125 individuals studied, 80 were found to be colonized by H. influenzae, and 36 carried multiply resistant strains. From patients and carriers, 77 strains were found to be resistant to ampicillin, chloramphenicol, and other drugs; 39 belonged to type b (cerebrospinal fluid, 16; blood, 4; ear, 7; and nasopharynx, 12) , and 38 were non-type b. The most frequent pattern of resistance was ampicillinchloramphenicol-tetracycline-sulfamethoxazole-trimethoprim (94.8%), followed by ampicillin-chloramphenicol-tetracycline (3.9%). The disk diffusion method correctly predicted multiple resistance. The mean inhibition zone diameters were: ampicillin, 12.8 mm; chloramphenicol, 15.2 mm; tetracycline, 9.9 mm; and sulfamethoxazole-trimethoprim, 10 .8 mm. These resistant strains were susceptible to cefotaxime, moxalactam, cefoperazone, cefuroxime, rifampin, and gentamicin. Our data suggest that in Spain the resistance of H. influenzae to ampicillin and chloramphenicol is endentic and that other effective therapeutic modalities are needed.
Ampicillin-resistant isolates of Haemophilus influenzae type b were first recognized in 1974 (2, 3) . Chloramphenicol continues to be the most widely accepted alternative to ampicillin, but occasionally chloramphenicol-resistant organisms have been found (4, 5 Also, we carried out a study of carriers in two different nurseries in which there were two children that had had meningitis caused by strains of H. influenzae resistant to The organisms were identified as H. influenzae by Gram stain and growth requirements of factors V and X on Mueller-Hinton agar. Isolates were typed by agglutination with specific antisera (Difco Laboratories) and biotyped by the Kilian method (10). Beta-lactamase production was detected by the rapid acidometric method (18) .
Antibiotic susceptibility studies. Strains were usually tested for beta-lactamase production and for susceptibility to four antibiotics (ampicillin, chloramphenicol, tetracycline, and sulfamethoxazole-trimethoprim [SMX-TMP]) by the disk diffusion method (18 Tables 3 and 4 .
Other studies. All ampicillin-and chloramphenicol-resistant strains were beta-lactamase producers. The MICs obtained by agar dilution and microdilution were found to be equal or within one doubling dilution of each other. By the disk diffusion method, all resistant strains were easily identified (Table 5) . For instance, all strains with MICs .8 ,ug/ml had inhibition zone diameters of <18 mm for chloramphenicol.
The susceptibilities to 10 additional drugs were tested on multiply resistant strains by the agar dilution method at two different inoculum sizes (Table 6 ). The most active drugs were cefotaxime, moxalactam, and cefoperazone, followed by cefuroxime, cefamandole, rifampin, and gentamicin. When a higher inoculum (106 CFU/ml) was used, an important effect was clearly seen for carbenicillin, cephalothin, and cefamandole. Inoculum effect was also apparent for ampicillin but not for chloramphenicol (data not shown).
Studies at the Centers for Disease Control (C. Thornsberry) confirmed our findings in regard to the susceptibilities of the 29 strains submitted. Discrepancies in susceptibilities to SMX-TMP were observed with three strains. By the tube dilution method, the MIC (determined at the Centers for Disease Control) required to inhibit these three strains was c0.6-0.03 ,ug/ml, and the MBC was >76-4 ,ug/ml. In our (16) in various parts of the world. Except for the latter publication, all of the others were case reports in which the isolation of such resistant strains was an exceptional finding. All of the strains described, except for one nontypable strain (8), belonged to serotype b and had been recovered from CSF (9, 16, 19) and the respiratory tract (8, 13, 16) .
The number and distribution of strains of H. influenzae resistant to ampicillin and chloramphenicol, as studied in this paper, constitute the most important description to date. Our strains originated just as often from nasopharyngeal carriers as from children suffering from meningitis, bacteremia, otitis, and conjunctivitis. They do not constitute a sporadic finding but a continuous problem over a prolonged period of time. No epidemiological link could be established among the cases with invasive diseases. They camne from different geographic areas, and we did not notice an accumulation of cases in the period of study. Accordingly, the emergence of multiply resistant strains seems to be an endemic problem in this country. We believe that the uncontrolled and widespread use of antibiotics in Spain over many years played a role in the emergence of these multiply resistant strains, as appears to be the case with pneumococcus in the same area (15 (5) A and SMX-TMP.3 (3.7) A, T, and SMX-TMP.2 (2.5) C, T, and SMX-TMP.2 (2.5) A, C, T, and SMX-TMP.36 (45) aStrains resistant to ampicillin (A), chloramphenicol (C), tetracycline (T), and SMX-TMP. (6) , cefotaxime (1), moxalactam (14) , and ceftriaxone (7) could constitute valid therapeutic alternatives because of their excellent activity against H. influenzae, whether producing beta-lactamase or not, and because of 
